⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PDSB News
PDS Biotechnology Corporation Common Stock
Form 8-K
sec.gov
PDSB
PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial
globenewswire.com
PDSB
Form 8-K
sec.gov
PDSB
PDS Biotech Reports Full Year 2025 Financial Results and Provides Update on PDS0101 Phase 3 Program and PDS01ADC Clinical Advancement
globenewswire.com
PDSB
PDS Biotech Announces Conference Call and Webcast for 2025 Fourth Quarter and Year End Financial Results
globenewswire.com
PDSB
Form 8-K
sec.gov
PDSB
Form 8-K
sec.gov
PDSB
Form 8-K
sec.gov
PDSB
PDS Biotech Announces Adoption of Amended Protocol for Phase 3 VERSATILE-003 Trial Incorporating Progression Free Survival (PFS) as Primary Endpoint for Interim Analysis and Potential Accelerated Approval
globenewswire.com
PDSB
Cancer Immunotherapy Research Report 2026: Market Forecasts 2025-2029 for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer with Executive and Consultant Guides
globenewswire.com
ABBV
ADAG
ADAP
ACET
ALXO
AMBR
AMGN
RCUS
AZN
ATRC
BBLU
BIIB
BNTX
BOLT
BMY
CRBU
CLDX
CRVS
LLY
EVAX
GNSS
GILD
GLSI
IMUX
IMMX
IMNM
INCY
INDP
ISRL
IOBT
JNJ
MRK
MRNA
MBIO
NVS
NVX
PDSB
PFE
REGN
SNY
SNT
URGN
ZYME